EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 317 filers reported holding EDITAS MEDICINE INC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $702,000 | -79.5% | 26,456 | -68.2% | 0.00% | -75.0% |
| Q3 2021 | $3,423,000 | -9.6% | 83,320 | +24.7% | 0.00% | 0.0% |
| Q2 2021 | $3,785,000 | +21.9% | 66,828 | -9.6% | 0.00% | 0.0% |
| Q1 2021 | $3,104,000 | +9.6% | 73,916 | +82.9% | 0.00% | 0.0% |
| Q4 2020 | $2,833,000 | +226.4% | 40,405 | +30.6% | 0.00% | +300.0% |
| Q3 2020 | $868,000 | +254.3% | 30,943 | +273.3% | 0.00% | – |
| Q2 2020 | $245,000 | -68.3% | 8,288 | -78.8% | 0.00% | -100.0% |
| Q1 2020 | $773,000 | +13.5% | 39,003 | +30.2% | 0.00% | +100.0% |
| Q3 2019 | $681,000 | +71.1% | 29,959 | +84.2% | 0.00% | 0.0% |
| Q1 2019 | $398,000 | -41.6% | 16,268 | -45.7% | 0.00% | -50.0% |
| Q4 2018 | $682,000 | -82.5% | 29,958 | -75.5% | 0.00% | -71.4% |
| Q3 2018 | $3,896,000 | +15.9% | 122,425 | +30.5% | 0.01% | 0.0% |
| Q2 2018 | $3,362,000 | – | 93,829 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |